{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:24:29Z","timestamp":1777037069156,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T00:00:00Z","timestamp":1310688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In Traditional Chinese Medicine (TCM) theory, functional dyspepsia (FD) can be divided into different syndromes according to different clinical symptoms and signs, and the most common one is spleen-deficiency and qi-stagnation syndrome that can be treated by Chinese traditional patent medicine ---- two kinds of Zhizhu pills, between which the primary difference in ingredients is that one contains immature orange fruit of Citrus aurantium L.(IFCA) and the other contains that of Citrus sinensis Osbeck (IFCS). The trial's objective was to compare the efficacy of two kinds of Zhizhu pills on symptom changes in patients with FD of spleen-deficiency and qi-stagnation syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A randomized, group sequential, double-blinded, multicenter trial was conducted in patients with FD of spleen-deficiency and qi-stagnation syndrome at 3 hospitals in Beijing between June 2003 and May 2005. Participants were randomly allocated into two groups (IFCA group and IFCS group) in a 1:1 ratio, and respectively took one of the two kinds of Zhizhu pills orally, 6 g each time, 3 times a day, for 4 weeks. Statistical analysis was performed with use of a group sequential method, the triangular test (TT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 163 patients were randomized, and 3 patients were excluded from analysis because of early dropouts, leaving 160 patients (IFCA group: n = 82; IFCS group: n = 78) for statistical analysis. Three interim analyses were done after 62, 116, and 160 patients had completed their 4-week treatment, respectively. At the third interim analysis, the sample path crossed the upper boundary and the trial was stopped, the cure-markedly effective rates were 45% for IFCS group and 67% for IFCA group, respectively, the one-sided <jats:italic>p<\/jats:italic>-value was 0.0036, the median unbiased estimate of the odds ratio (OR) for the benefit of IFCA relative to IFCS was 2.91 with 95%CI: 1.40 to 6.06.<\/jats:p>\n            <jats:p>No adverse events were observed in the two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Zhizhu pills containing IFCA was superior to Zhizhu pills containing IFCS in the treatment of FD of spleen-deficiency and qi-stagnation syndrome. The application of group sequential analysis in clinical trials of TCM may offer some financial and ethical benefits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial Registration<\/jats:title>\n            <jats:p>Chinese Clinical Trial Registry (ChiCTR): ChiCTR-TRC-00000485<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-11-81","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T18:19:29Z","timestamp":1310753969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["To compare the efficacy of two kinds of Zhizhu pills in the treatment of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome:a randomized group sequential comparative trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Hongli","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,15]]},"reference":[{"key":"619_CR1","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/gut.45.2008.ii37","volume":"45","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Stanghellini V, Heading RC: Functional gastroduodenal disorders. Gut. 1999, 45: 1137-1142.","journal-title":"Gut"},{"issue":"Suppl 1","key":"619_CR2","first-page":"RS25","volume":"11","author":"P Malfertheiner","year":"1999","unstructured":"Malfertheiner P: Current concepts in dyspepsia: a world perspective. Eur J Gastroenterol Hepatol. 1999, 11 (Suppl 1): RS25-29.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"619_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/gut.46.5.741b","volume":"46","author":"R Spiller","year":"2000","unstructured":"Spiller R: Rome II: the functional gastrointestinal disorders. diagnosis, pathophysiology and treatment: a multinational consensus. Gut. 2000, 46: 741-10.1136\/gut.46.5.741.","journal-title":"Gut"},{"key":"619_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2036.2004.01897.x","volume":"19","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Talley NJ: Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004, 19: 643-654. 10.1111\/j.1365-2036.2004.01897.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"619_CR5","first-page":"191","volume":"22","author":"X Kang","year":"2002","unstructured":"Kang X, Liu Z, Xie B: The incidence of functional dyspepsia of parts of citizens in Tianjin. Chinese Journal of Digestion. 2002, 22: 191-192.","journal-title":"Chinese Journal of Digestion"},{"key":"619_CR6","first-page":"54","volume-title":"Guiding principle of clinical research on new drugs of Chinese medicine (trial implementation)","author":"XY Zheng","year":"2002","unstructured":"Zheng XY: Guiding principle of clinical research on new drugs of Chinese medicine in the treament of stuffiness and fullness. Guiding principle of clinical research on new drugs of Chinese medicine (trial implementation). Edited by: Yu XH. 2002, Bejing, Chinese Medical Science and Technology Press, 54-58."},{"key":"619_CR7","first-page":"778","volume-title":"Pharmacopoeia of the People's Republic of China","author":"China Pharmacopoeia Committee","year":"2005","unstructured":"China Pharmacopoeia Committee: Zhizhu Wan(Pills). Pharmacopoeia of the People's Republic of China. Edited by: China Pharmacopoeia Committee. 2005, Beijing, China Medical Science Press, I: 778-English","edition":"English"},{"key":"619_CR8","first-page":"76","volume-title":"The design and analysis of sequential clinical trials(Revised second Edition)","author":"J Whitehead","year":"1997","unstructured":"Whitehead J: The triangular test. The design and analysis of sequential clinical trials(Revised second Edition). Edited by: Barnett V. 1997, Chichester, John Wiley & Sons Ltd, 76-87."},{"key":"619_CR9","first-page":"1","volume-title":"Statistical Methods in Medical Research","author":"J Whitehead","year":"2010","unstructured":"Whitehead J: Group sequential trials revisited:Simple implementation using SAS. Statistical Methods in Medical Research. 2010, 1-22."},{"key":"619_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/1756283X10362639","volume":"3","author":"B Rita","year":"2010","unstructured":"Rita B, Braden K: Functional dyspepsia. Ther Adv Gastroenterol. 2010, 3: 145-164. 10.1177\/1756283X10362639.","journal-title":"Ther Adv Gastroenterol"},{"key":"619_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1572-0241.1998.00368.x","volume":"93","author":"JM Hansen","year":"1998","unstructured":"Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB: Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol. 1998, 93: 368-374. 10.1111\/j.1572-0241.1998.00368.x.","journal-title":"Am J Gastroenterol"},{"key":"619_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Par\u00e9 P: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998, 12: 1055-1065. 10.1046\/j.1365-2036.1998.00410.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"619_CR13","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/S0016-5085(97)80016-9","volume":"113","author":"NJ Talley","year":"1997","unstructured":"Talley NJ, Hunt RH: What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology. 1997, 113: S67-77. 10.1016\/S0016-5085(97)70081-7.","journal-title":"Gastroenterology"},{"key":"619_CR14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/j.1460-2075.1995.tb07080.x","volume":"14","author":"RT Pu","year":"1995","unstructured":"Pu RT, Osmani SA: Mitotic destruction of the cell cycle regulated NIMA protein kinase of Aspergillus nidulans is required for mitotic exit. EMBO J. 1995, 14: 995-1003.","journal-title":"EMBO J"},{"key":"619_CR15","first-page":"18","volume":"3","author":"W Xijun","year":"2007","unstructured":"Xijun W, Xi C, Hongxin C: Pharmacokinetic studies of naringenin and hesperetin in human plasma after oral administration of Zhizhu Wan. Chinese Journal of Experimental Traditional Medicine Formulae. 2007, 3: 18-20.","journal-title":"Chinese Journal of Experimental Traditional Medicine Formulae"},{"key":"619_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1214\/aoms\/1177705996","volume":"31","author":"TW Anderson","year":"1960","unstructured":"Anderson TW: A modification of the sequential probability ratio test to reduce the sample size. The Annals of Mathematical Statistics. 1960, 31: 165-197. 10.1214\/aoms\/1177705996.","journal-title":"The Annals of Mathematical Statistics"},{"key":"619_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2307\/2530822","volume":"39","author":"J Whitehead","year":"1983","unstructured":"Whitehead J, Stratton I: Group sequential clinical trials with triangular continuation regions. Biometrics. 1983, 39: 227-236. 10.2307\/2530822.","journal-title":"Biometrics"},{"key":"619_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1042\/cs0980569","volume":"98","author":"V Sebille","year":"2000","unstructured":"Sebille V, Bellissant E: Comparison of four sequential methods allowing for early stopping of comparative clinical trials. Clin Sci. 2000, 98: 569-578. 10.1042\/CS19990336.","journal-title":"Clin Sci"},{"key":"619_CR19","first-page":"21","volume":"46","author":"E Bellissant","year":"1991","unstructured":"Bellissant E, B\u00e9nichou J, Chastang C: Design and analysis of phase II trials in oncology with a group sequential method, the triangular test. Therapie. 1991, 46: 21-27.","journal-title":"Therapie"},{"key":"619_CR20","first-page":"11","volume":"12","author":"T Lin","year":"2005","unstructured":"Lin T, Sheng-sheng Z, Hong-bing W: Clinical Research on the prescription of Invigorating spleen with regulating qi and promoting blood circulation in treating 50 cases of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome. Chinese Journal of Information on Traditional Chinese Medicine. 2005, 12: 11-13.","journal-title":"Chinese Journal of Information on Traditional Chinese Medicine"},{"key":"619_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000121347","volume":"26","author":"NJ Talley","year":"2008","unstructured":"Talley NJ, Ruff K, Jiang X: The Rome III Classification of dyspepsia: will it help research?. Dig Dis. 2008, 26: 203-209. 10.1159\/000121347.","journal-title":"Dig Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-11-81\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-81","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:22:47Z","timestamp":1630509767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-11-81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,15]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-11-81","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,15]]},"assertion":[{"value":"21 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"81"}}